About SINSAN PHARMACEUTICALS PRIVATE LIMITED
SINSAN PHARMACEUTICALS PRIVATE LIMITED is a Private Limited Company and was incorporated on Oct 30, 2007 in India. It is registered at Registrar of Companies, ROC Pune. Its registered address is 5th Floor, Park plaza, Ketkar road opp Kamala Nehru Park Pune, Pune, Pune, Maharashtra, India, 411004. Its corporate identification number is (CIN) U24232PN2007PTC130928 and its current status is Active. Its industry classification as per MCA is manufacture Of Allopathic Pharmaceutical Preparations.
SINSAN PHARMACEUTICALS PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2025 as per records from Ministry of Corporate Affairs (MCA). SINSAN PHARMACEUTICALS PRIVATE LIMITED's authorised share capital is ₹4.99Cr and its paid up capital is ₹4.95Cr. The current board of directors of SINSAN PHARMACEUTICALS PRIVATE LIMITED comprises Mahendra Champalal Jain, Rajeshkumar Champalal Jain and 1 more.
SINSAN PHARMACEUTICALS PRIVATE LIMITED generated between ₹10 Cr and ₹50 Cr in revenue for the financial year ending on Mar 31, 2025.
Contact Details for SINSAN PHARMACEUTICALS PRIVATE LIMITED
- *****@gmail.com
- Registered Address
- 5th Floor, Park plaza, Ketkar road opp Kamala Nehru Park Pune, Pune, Pune, Maharashtra, India, 411004
Brands associated with SINSAN PHARMACEUTICALS PRIVATE LIMITED
Name | Short Description | Founded Year | Location | Current Stage |
|---|---|---|---|---|
Manufacturer of drugs | 2007 | Unfunded |
Principal Business Activity of SINSAN PHARMACEUTICALS PRIVATE LIMITED
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles | mak |
Auditor Details of SINSAN PHARMACEUTICALS PRIVATE LIMITED
Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
MAHENDRA SHAH & CO | bkwgsnb | dl{jpgz | uzwlfwv |
Documents of SINSAN PHARMACEUTICALS PRIVATE LIMITEDFY 25 Available15 mins
Filing Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
List of share holders, debenture holders; | Annual Returns and Balance Sheet eForms | Dec 06, 2025 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Dec 06, 2025 |
Form MGT-7 | Annual Returns and Balance Sheet eForms | Dec 06, 2025 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 03, 2025 |
e-Director’s Report | Annual Returns and Balance Sheet eForms | Dec 03, 2025 |
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents) | Annual Returns and Balance Sheet eForms | Dec 03, 2025 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 03, 2025 |
Form AOC-4 | Annual Returns and Balance Sheet eForms | Dec 03, 2025 |
Form DPT-3 | Other eForm Documents | Jun 28, 2025 |
Form MGT-7 | Annual Returns and Balance Sheet eForms | Nov 25, 2024 |
Financials of SINSAN PHARMACEUTICALS PRIVATE LIMITEDFY 25 Available15 mins
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 5249 | 9378 | 5052 | 5713 | 4687 |
Total Sales | 6739 | 5478 | 2761 | 5040 | 7807 |
Total Expenses | 5986 | 1344 | 1175 | 4735 | 9365 |
Operating Expenses | 2059 | 7667 | 9252 | 2484 | 7667 |
Employee Expenses | 2912 | 9591 | 6195 | 5095 | 9913 |
Operating Income (EBIT) | 9623 | 8719 | 1612 | 2148 | 9963 |
Interest Expenses | 6251 | 8083 | 8807 | 7298 | 3583 |
Expenses from other activities | 3674 | 2842 | 5627 | 7386 | 8037 |
EBITDA | 5500 | 4784 | 3207 | 3621 | 6647 |
Taxes | 6400 | 9466 | 9710 | 3928 | 6233 |
Net Profit | 9263 | 3896 | 1913 | 5144 | 8776 |
Balance Sheet | |||||
Assets | 9365 | 7275 | 5548 | 2529 | 3680 |
Accounts Receivables | 3719 | 8054 | 1963 | 6428 | 2771 |
Inventory | 3022 | 5707 | 1705 | 9415 | 3257 |
Liabilities | 5118 | 3644 | 6183 | 8859 | 1047 |
Total Debt | 8480 | 5746 | 1031 | 6814 | 9934 |
Accounts Payable | 2875 | 4645 | 8018 | 1444 | 3992 |
Equities | 1539 | 7722 | 6711 | 4363 | 7010 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 1213 | 6603 | 8271 | 5605 | 9288 |
EBIT Margin | 3461 | 7333 | 8909 | 3530 | 8738 |
Net Profit Margin | 3925 | 8641 | 7602 | 9387 | 8821 |
Return on Assets (ROA) | 5067 | 3413 | 3903 | 4593 | 7569 |
Return on Equity (ROE) | 1782 | 2245 | 7757 | 6593 | 2824 |
Return on Capital Employed | 4407 | 3225 | 8575 | 2337 | 5902 |
Return on Invested Capital | 1115 | 6835 | 5132 | 7770 | 2866 |
Efficiency Ratios | |||||
Asset Turnover | 5994 | 6233 | 9501 | 6830 | 5591 |
Receivables Turnover | 9091 | 7629 | 2733 | 8066 | 1285 |
Days Sales Outstanding | 9783 | 5654 | 5289 | 1617 | 8523 |
Inventory Turnover | 9830 | 6451 | 4595 | 8363 | 5836 |
Days Inventory Outstanding | 7573 | 9803 | 9575 | 3305 | 1994 |
Payables Turnover | 5924 | 7887 | 8911 | 9904 | 6663 |
Days Payables Outstanding | 7116 | 2859 | 5159 | 4928 | 7303 |
Liquidity Ratios | |||||
Current Ratio | 2087 | 6107 | 1072 | 3729 | 2882 |
Quick Ratio | 6031 | 8861 | 4243 | 3848 | 9075 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 9597 | 3255 | 1839 | 1868 | 1589 |
Debt Ratio | 7197 | 2903 | 6087 | 6921 | 6717 |
Interest Coverage Ratio | 8323 | 7135 | 5370 | 3568 | 5254 |
Debt Service Coverage Ratio | 2792 | 8581 | 8318 | 6171 | 7114 |
Net Debt/EBITDA | 4060 | 6692 | 5318 | 9769 | 2559 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 2875 | 8108 | 8122 | 9797 | 3665 |
Earnings Growth Rate (CAGR) | 4710 | 6836 | 3594 | 3048 | 4659 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of SINSAN PHARMACEUTICALS PRIVATE LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | -6% |
3 Year | 344 |
5 Year | 409 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 17% |
3 Year | 246 |
5 Year | 665 |
MSME Payment Delays by SINSAN PHARMACEUTICALS PRIVATE LIMITED
Loans and Charges on SINSAN PHARMACEUTICALS PRIVATE LIMITED
As a Borrower
Loan/ Charge ID | Lender Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
100417769 | - | ₹2Cr | {i{o{zf | Jan 30, 2021 | zgphwkd |
100338690 | - | ₹1.23Cr | sbpmthr | Apr 04, 2020 | pejpeci |
100323807 | - | ₹7.4L | zzy{zjv | Feb 03, 2020 | ubedozt |
100312358 | - | ₹1Cr | uvjvmsw | Dec 07, 2019 | wyrmqin |
100036279 | - | ₹50L | zjdciim | Jun 06, 2016 | ub{tmsr |
10612974 | - | ₹12.3Cr | ffaomjj | Dec 16, 2015 | easallz |
Credit Ratings of SINSAN PHARMACEUTICALS PRIVATE LIMITED
GSTIN Details of SINSAN PHARMACEUTICALS PRIVATE LIMITED
Board of Directors and Signatories of SINSAN PHARMACEUTICALS PRIVATE LIMITED
Board of Directors of SINSAN PHARMACEUTICALS PRIVATE LIMITED
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Aug 25, 2010 | 15 Years 10 Months | |
Director | Current | Aug 25, 2010 | 15 Years 10 Months | |
Director | Current | Aug 25, 2010 | 15 Years 10 Months |
Signatories of SINSAN PHARMACEUTICALS PRIVATE LIMITED
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Aug 25, 2010 | 15 Years 10 Months | |
Director | Current | Aug 25, 2010 | 15 Years 10 Months | |
Director | Current | Aug 25, 2010 | 15 Years 10 Months |
Cross Directorships of SINSAN PHARMACEUTICALS PRIVATE LIMITED
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
M/s Sinsan Pharmaceuticals Pvt Ltd CIN: U24232PN2007PTC130928, India, Active | 109 | 950 | 413 | 238 |
JODHAWAT CONSTRUCTION COMPANY PRIVATE LIMITED CIN: U45200PN2008PTC132342, India, Active | 696 | 417 | 851 | 273 |
XION PHARMACEUTICALS PRIVATE LIMITED CIN: U24231PN2007PTC130248, India, Active | 514 | 674 | 391 | 446 |
SINSAN LIFESCIENCES PRIVATE LIMITED CIN: U21002PN2026PTC253054, India, Active | 796 | 478 | 435 | 216 |
ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED CIN: U24231PN2006PTC022042, India, Active | 475 | 241 | 123 | 190 |
H. M. & COMPANY MEDISALES PRIVATE LIMITED CIN: U51397PN2011PTC139924, India, Active | 246 | 593 | 654 | 874 |
ZYPHAR'S BIOPHARMACEUTICALS PRIVATE LIMITED CIN: U24299PN2021PTC206752, India, Active | 597 | 748 | 754 | 626 |
KROME - JRB DEVELOPERS PRIVATE LIMITED CIN: U70102PN2011PTC138359, India, Active | 119 | 235 | 917 | 544 |
SKIN AESTHETICS INTERNATIONAL PRIVATE LIMITED CIN: U74900PN2012PTC145328, India, Active | 570 | 425 | 615 | 158 |
ARIHANT CHEMIST (VARANASI) PRIVATE LIMITED CIN: U46497UP2024PTC208265, India, Active | 330 | 439 | 740 | 872 |